Alumni raised $1.45B in 2022 - Download Free Report Now


Patient-specific epigenetic therapeutics utilizing small molecule histone methyltransferase (HMT) inhibitors for the treatment of cancer.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Epizyme plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Epizyme

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With